Equasens Société anonyme (EQS) Q3 2025 TU earnings summary

Executive summary

• Revenue reached €172.2m at 30 September 2025, up 8.9% reported and 7.3% like-for-like year-over-year.

• Q3 2025 saw strong performance with 12.1% reported revenue growth and 9.4% like-for-like growth.

• Growth was driven by systems and equipment sales, recurring revenues, and software solutions.

Financial highlights

• Systems and equipment revenue rose 13.1% to €69.1m at 30 September, with Q3 up 20.7%.

• Maintenance and subscriptions (recurring revenue) increased 6.2% to €77.9m, aided by acquisitions.

• Software and services revenue grew 6.4% to €25.0m.

• Acquisitions contributed €2.4m to revenue, with Calimed and Novaprove/DIS notable additions.

Outlook and guidance

• Guidance maintained for nearly 10% reported revenue growth in H2 2025.

• Focus remains on external growth opportunities to expand services and European presence.